COVALAB Email Format
Biotechnology ResearchAuvergne-rhône-alpes, France11-50 Employees
COVALAB is a French biotechnology company founded in 1995 that specializes in antibody engineering. Based in Bron, in the Auvergne-Rhône-Alpes region, it develops and manufactures a range of antibodies and related products, including polyclonal and monoclonal formats, as well as engineered fragments, with capabilities spanning antigen or DNA immunization and both purified and labeled antibodies. The company serves researchers and diagnostic or therapeutic development efforts by supplying high-quality antibodies and related services, alongside peptide synthesis for research use. Its experienced team emphasizes chemical modification of antigens and antibodies to support translational research, personalized medicine, stem cell therapy, and food safety, addressing challenges across biomedical and agro-food applications. In recent years, Covalab has highlighted activities related to antibody constructs for CAR-T cell applications, reflecting ongoing efforts to broaden its portfolio beyond traditional diagnostics and therapeutics.